Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Promyelocytic, Acute 4Leukemia 3Neuroblastoma 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Wilms Tumor 1Testicular Neoplasms 1Teratoma 1Skin Neoplasms 1Sarcoma 1Retinoblastoma 1Recurrence 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Kidney Neoplasms 1Hepatoblastoma 1Endometrial Neoplasms 1Desmoplastic Small Round Cell Tumor 1Childhood Acute Promyelocytic Leukemia With PML-RARA 1Central Nervous System Neoplasms 1Carcinoma, Small Cell 1

Interventions

Cytarabine 167fludarabine phosphate 102Cyclophosphamide 97Azacitidine 92Whole-Body Irradiation 78fludarabine 77Mycophenolic Acid 71Busulfan 68Tacrolimus 59Peripheral Blood Stem Cell Transplantation 55Decitabine 55Granulocyte Colony-Stimulating Factor 49Filgrastim 44Daunorubicin 44Cyclosporine 42Methotrexate 41Melphalan 41Etoposide 41Clofarabine 41Idarubicin 39Mitoxantrone 34Antilymphocyte Serum 34venetoclax 32thymoglobulin 23Thiotepa 23Stem Cell Transplantation 21Injections 16Gemtuzumab 16CPX-351 16Sirolimus 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Leukemia, Myeloid, Acute × Arsenic Trioxide × Clear all
NCT00184054 2014-07-25

Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia

University of Southern California

Phase 2 Terminated
11 enrolled 7 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00513305 2012-08-01

Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid Leukemia

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 3 Terminated
67 enrolled 15 charts
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡